Humacyte Inc. (HUMAW)
1.59
0.04 (2.58%)
At close: Jan 15, 2025, 1:41 PM
undefined% (undefined)
| Bid | 1.5 |
| Market Cap | 204.57M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -3.158 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.6 |
| Volume | 9,420 |
| Avg. Volume (20D) | 0 |
| Open | 1.51 |
| Previous Close | 1.55 |
| Day's Range | 1.43 - 1.59 |
| 52-Week Range | 1.43 - 1.59 |
| Beta | undefined |
About HUMAW
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immu...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 183
Stock Exchange NASDAQ
Ticker Symbol HUMAW